The Use of Vaccines in the Prevention and Treatment of Cervical Cancer

This publication has 77 references indexed in Scilit:

• Human papillomarivus vaccines for cervical cancer
  Current Opinion in Immunology, 1996
• Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls from Colombia and Spain
  The Journal of Infectious Diseases, 1995
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995
• The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
  International Journal of Cancer, 1995
• Surrogate endpoint biomarkers for cervical cancer chemoprevention trials
  Journal of Cellular Biochemistry, 1995
• Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.
  Genes & Development, 1994
• Papillomavirus, p53 alteration and primary carcinoma of the vulva
  European Journal Of Cancer, 1993
• Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
  Cell, 1992
• Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA
  International Journal of Cancer, 1992
• Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
  Nature, 1985